129 related articles for article (PubMed ID: 1183914)
21. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
[TBL] [Abstract][Full Text] [Related]
22. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
23. [Changes in carbohydrate metabolism during the administration of progestational hormones].
Vela P
Rev Chil Obstet Ginecol; 1970; 35(2):40-9. PubMed ID: 5531975
[TBL] [Abstract][Full Text] [Related]
24. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults.
Weltman A; Despres JP; Clasey JL; Weltman JY; Wideman L; Kanaley J; Patrie J; Bergeron J; Thorner MO; Bouchard C; Hartman ML
Metabolism; 2003 Jan; 52(1):73-80. PubMed ID: 12524665
[TBL] [Abstract][Full Text] [Related]
25. Remission phase in newly diagnosed insulin treated juvenile diabetes: behaviour of glucose, FFA, HGH and total-IRI during combined glucose arginine infusion; development of antibodies against exogenous insulin.
Menzel R; Michaelis D; Neumann I; Schultz B; Wilke W; Wulfert P; Michael R; Bibergeil H
Endokrinologie; 1973 Aug; 62(1):100-6. PubMed ID: 4785266
[No Abstract] [Full Text] [Related]
26. Diabetes mellitus and sexual ateliotic dwarfism: a comparative study.
Merimee TJ; Fineberg SE; McKusick VA; Hall J
J Clin Invest; 1970 Jun; 49(6):1096-102. PubMed ID: 5422015
[TBL] [Abstract][Full Text] [Related]
27. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic alpha and beta cell function in familial dysbetalipoproteinemia.
Tan MH; Havel RJ; Gerich JE; Soeldner JS; Kane JP
Horm Metab Res; 1980 Sep; 12(9):421-5. PubMed ID: 7000652
[TBL] [Abstract][Full Text] [Related]
29. Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects.
Olefsky J; Reaven GM; Farquhar JW
J Clin Invest; 1974 Jan; 53(1):64-76. PubMed ID: 4357617
[TBL] [Abstract][Full Text] [Related]
30. Recombinant deoxyribonucleic acid-derived 22K- and 20K-human growth hormone generate equivalent diabetogenic effects during chronic infusion in dogs.
Ader M; Agajanian T; Finegood DT; Bergman RN
Endocrinology; 1987 Feb; 120(2):725-31. PubMed ID: 3542508
[TBL] [Abstract][Full Text] [Related]
31. [Studies on glucose, amino acid and protein metabolism in patients with liver cirrhosis in relation to plasma levels of human growth hormone (author's transl)].
Ogura C
Hokkaido Igaku Zasshi; 1975 Sep; 50(5):489-506. PubMed ID: 815150
[TBL] [Abstract][Full Text] [Related]
32. Effect of the antihistaminic agents meclastine and dexchlorpheniramine on the response of human growth hormone to arginine infusion and insulin hypoglycemia.
Pontiroli AE; Viberti G; Vicari A; Pozza G
J Clin Endocrinol Metab; 1976 Sep; 43(3):582-6. PubMed ID: 956343
[TBL] [Abstract][Full Text] [Related]
33. Hormonal and metabolic changes induced by elevated plasma free fatty acids in term pregnancy. I. Effect on maternal blood glucose, insulin and human placental lactogen circulating levels.
Gaspard UJ; Sandront HM; Luyckx AS; Lefebvre PJ
J Clin Endocrinol Metab; 1975 Jun; 40(6):1066-72. PubMed ID: 1133156
[TBL] [Abstract][Full Text] [Related]
34. Effect of metergoline, a specific serotonin antagonist, on human growth hormone response to arginine and L-dopa.
Pontiroli AE; Viberti GC; Tognetti A; Pozza G
Horm Metab Res; 1976 Mar; 8(2):106-8. PubMed ID: 1261961
[TBL] [Abstract][Full Text] [Related]
35. Effect of deflazacort on growth hormone response to insulin tolerance test.
LoCascio V; Francia G; Daví MV; Olivieri M; Adami S; Cominacini L; Rossi L
Horm Metab Res; 1992 Jul; 24(7):333-5. PubMed ID: 1516890
[TBL] [Abstract][Full Text] [Related]
36. Chronic baclofen therapy improves the blunted growth hormone response to intravenous arginine in subjects with spinal cord injury.
Bauman WA; Spungen AM; Zhong YG; Tsitouras PD
J Clin Endocrinol Metab; 1994 May; 78(5):1135-8. PubMed ID: 8175969
[TBL] [Abstract][Full Text] [Related]
37. Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment.
Tiengo A; Muggeo M; Assan R; Fedele D; Crepaldi G
Metabolism; 1975 Aug; 24(8):901-14. PubMed ID: 1143089
[TBL] [Abstract][Full Text] [Related]
38. Influence of triglyceridemia level on glucose tolerance and insulinemia in subjects with type IV hyperlipoproteinemia.
Debry G; Drouin P; Mejean L
Horm Metab Res; 1974 Sep; 6(5):421-2. PubMed ID: 4425070
[No Abstract] [Full Text] [Related]
39. Exaggerated growth hormone response to arginine infusion in Huntington's disease.
Leopold NA; Podolsky S
J Clin Endocrinol Metab; 1975 Jul; 41(1):160-3. PubMed ID: 125287
[TBL] [Abstract][Full Text] [Related]
40. Growth hormone response to insulin and to arginine in patients with familial hypercholesterolaemia.
Muggeo M; Tiengo A; Fedele D; Crepaldi G
Atherosclerosis; 1975; 22(3):543-50. PubMed ID: 1201152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
